Related by context. Frequent words. (Click for all words.) 64 mg kg dose 64 noninferiority 63 prospectively defined 62 goserelin 62 elotuzumab 62 efficacy endpoint 62 pharmacokinetic PK 62 mg QD 61 PRECiSE 61 mRCC 61 Engerix B 61 GSK# [001] 61 Cethromycin 61 tocilizumab 61 subanalysis 60 J Clin Oncol 60 statistically significant p = 60 ACR# response 60 Phase Ib clinical 60 Traficet EN 60 placebo controlled clinical 60 clinically meaningful improvement 60 Dasatinib 60 Randomized controlled 60 Solid Tumors 60 achieved statistical significance 60 μmol L 60 fluvastatin 60 eplerenone 60 EORTC 60 prespecified 59 irbesartan 59 Pharmacokinetic 59 nonrandomized 59 virologic response 59 TYGACIL 59 bicalutamide 59 tipranavir 59 chlorambucil 59 peginterferon alfa 2a 58 Response Evaluation Criteria 58 PEG SN# 58 tolvaptan 58 ximelagatran 58 COPAXONE R 58 paclitaxel eluting stents 58 Phase 2a trial 58 XELOX 58 pharmacokinetics PK 58 decitabine 58 patients evaluable 58 glatiramer acetate 58 secondary efficacy endpoints 58 SABCS 58 nelfinavir 58 ATL# [001] 58 peginterferon alfa 2b 58 TRITON TIMI 58 Natalizumab 58 virologic failure 58 univariate analysis 58 % CI #.#-#.# [003] 58 bendamustine 58 adecatumumab 58 mcg dose 58 PROMACTA 57 interferon beta 1b 57 FOLFIRI 57 Phase IIB 57 liposomal formulation 57 intravesical 57 tigecycline 57 IRESSA 57 plus prednisone 57 seroprotection 57 Fibrillex TM 57 mycophenolate mofetil 57 GFT# 57 plus dexamethasone 57 Multicenter 57 NLX P# 57 Amrubicin 57 secondary endpoint 57 MIRCERA 57 NSABP 57 TOLAMBA 57 ZD# [001] 57 febuxostat 57 nonresponders 57 #:#-# [035] 57 Sym# 57 C2L 57 subgroup analyzes 57 ILUVIEN 57 chemoradiotherapy 57 annualized relapse 57 relapsed refractory multiple myeloma 57 QTc 57 complete cytogenetic 57 #:#-# [029] 56 daptomycin